ABBOTT LABORATORIES — Director's Dealing 2008

May 17, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-05-14

Reporting Person: Michael Edward L (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-05-14	Common shares without par value	S	9936	$55.00	Disposed	134416	Direct
2008-05-14	Common shares without par value	M	40433	$42.4978	Acquired	174849	Direct
2008-05-14	Common shares without par value	M	23232	$32.6111	Acquired	198081	Direct
2008-05-14	Common shares without par value	F	51986	$54.40	Disposed	146095	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-05-14	Option (right to buy)	$42.4978	M	40433	Disposed	2009-02-11	Common Shares (40433)	Direct
2008-05-14	Option (right to buy)	$32.6111	M	20167	Disposed	2010-02-10	Common Shares (20167)	Direct
2008-05-14	Option (right to buy)	$32.6111	M	3065	Disposed	2010-02-10	Common Shares (3065)	Direct
2008-05-14	Option (right to buy)	$54.40	A	34873	Acquired	2009-02-11	Common Shares (34873)	Direct
2008-05-14	Option (right to buy)	$54.40	A	17113	Acquired	2010-02-10	Common Shares (17113)	Direct

Footnotes

F1: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.